Showing results (1-10 of 751) with videos related to
Sort By:
Pageof 76
Vaccine|June 10, 2025
It's time to change how we vaccinate for measlesBenjamin L Sievers, Eric L SieversOpen Forum Infectious Diseases|June 29, 2023
Inundative, Dry-Powder, Inhaled Measles Vaccination to Prevent Deaths of Young Children in War-torn RegionsBenjamin L Sievers, Robert E Sievers, Eric L SieversJournal of Virus Eradication|December 29, 2022
Incentivized self-vaccination for global measles eradicationBenjamin L Sievers, Robert E Sievers, Eric L SieversExpert Opinion on Biological Therapy|December 1, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapseE L SieversDiabetes|June 1, 1976
Diabetes mellitus in American Indians - standards for diagnosis and managementM L SieversCurrent Opinion in Oncology|February 25, 2000
Clinical studies of new "biologic" approaches to therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugatesE L SieversCancer Chemotherapy and Pharmacology|August 19, 2000
Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugatesE L SieversBlood Cells, Molecules & Diseases|July 10, 2003
Antibody-targeted chemotherapy of acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg)Eric L SieversHistochemistry|January 1, 1986
Reabsorption of fluorescein-isothiocyanate-labelled-ovalbumin in the kidney of normal and castrated male and female ratsL Sievers, P KuglerCurrent Opinion in Oncology|October 24, 2001
Mylotarg: antibody-targeted chemotherapy comes of ageE L Sievers, M LinenbergerPageof 76